miRNA Infomation | |
---|---|
miRNA name | mmu-miR-1194 |
Gene Information | |
---|---|
Gene Symbol | Usp29 |
Synonyms | Ocat |
Description | ubiquitin specific peptidase 29 |
Transcript | NM_021323 |
Expression | |
Putative miRNA Targets on Usp29 | |
3'UTR of Usp29 (miRNA target sites are highlighted) |
>Usp29|NM_021323|3'UTR 1 ATCCTGCCTAAAATGAAGAAGAGTCACATAGCTCAAGATGAAAACTTGACATAAAACAACGAACGGACATAAAACAACGA 81 ACGGACATAAAACAACGAACGGACATATTAGAACAGAAACACAGGCCTTGCTGATGCAGGCTATGCACCATTCTTTCCTA 161 TAAGGCTAAATGGTGCTTTTCCTGTTTTGTGGTGGTTTTAATTTATTCACAGATGTTAAGAAAACTCATCATTTTGAGAG 241 TACCATTTGTTAACGTAATAGGGATCTGGAGAGATGGTGGAGTAGTTGAGAGTGCAAACTTCTCCCATAGAGGACCCAAG 321 CTTGACTTCCCAATACCTGTGTTAGGTGTGAGCGCATGTGTCCTTGGAGACAGGAGGCATGGGATCACCCGGAATGCGAA 401 TTACAAGTGAGAGTGAGCTGCCTGGCTTGGGTGCTGGGAACTGAACTTAGGTCTTCTGCAAGGACAGTTTCCACTTTTAA 481 ACACTAAGCCATCTCTTGGCTTTCATTCTAATTTTAGTGTGTGTGCTATCCGTATGAGCAAAGCATGATGCTTTTTAAAC 561 GTTGTTCTGAACCAATACAACACAGCAAGGAACCAATTACAAGTTCAAATGCTGGGGTTCAATGTCAGAAACAATACCAG 641 TAGTTACTTAAAAGTTTGAGAAACATTTATTTAGTGTGTGGAGTGTCCTATTAAATTTTAGTGTATATATAAATCGCTCA 721 TGTCATCCAGAGGTTCCTCATTTTTTTCCCTAAATTCATATGTGTTGTTGTTTTGTCAATTTATTAAAACCATTGTTTTC 801 CATGTGTGTTTGTGATTCATCGATGAGATCATATAGTTGCCCACCACCTGGTTTTGTGCTTCTCAGAATTACAGGGTACA 881 TTAAAGTTACACAGGAAATGAAATAGATAGTATTTGCAAATTGAAAAGCACTCTAAGGACTCTGGGTAAAAACACCTGCC 961 ACCAAGCCCCATGACCCAACTCTAATGAGTTGCCCTCTGACCTCTAGGGAAGCTATCACATGAACACCCATAAACAGATG 1041 GATGAATAAAATCTAACTTTCTAAAGGTTTACTCATTTACTGTGTGTGTGTATATATATATATATATATATATATTATAT 1121 ATAGTGTTCTGCCTTCTTGTAGGCCTACACATCAGAAGAGAGCACCAGATCTCATTATAAATGATTGTGAGCCACCATGA 1201 GGCTGTTGGGAATTGAGCTCAGGACTTCTGGAAGAACAGCCAGTACTCTTAACCCCTGAGCCATCTCTCTATCCCCTAAA 1281 ATTTGTTTTTTTTTTTTTTTTGAAATCTCACTATATGGCTGGCTTGGGACTTTGTATAGATCAGGCTACCCCTAAACTCA 1361 AGAGATTTGCCCTGCCTCTTGGGTGCTGGTATTGAAGATCTGCACCACCATGCCTAACACAATGAGAATTTAAAAGCACT 1441 TTAAAGTGCCAAATATACTTGTTAAGATTTAAATCAGGATTGACATGAGAAAATGGGGTGGTTCAAGGTAGAGGATAAGT 1521 GTTAGACTGTCCTGCAGGTGAGAGCTTCGTTAGAAATAGTAATACCACAAACGGCAGAGTGGGATTCTAAAGAGAGAACC 1601 TTCAGCTCAGAAGAGAAAGCAAGGTTCCCCTTAATTTCCAAGAGCCCCATGCCATAAAGCAGTTAAAGAGCAGCGCATGC 1681 TTTCCCCTGGTTCTGGGCTGCAAGGGGAAGGCAACAATAAGTTGGTGTCACTGTCTACATGGTGTGTAGCTTGATCTGAG 1761 ACACCAACACCACATCTAATAGTGATTCAAACATGAAAAAATTAGTCACTTTCAAGGGTCTAGGGAGATAGTTCAGTAGG 1841 TAAGGGTCATGTGCAAGCATGGGGACTTGAGTTCAAATCCCCAGCACCCACTTAAGGTGGTCATGGGCATAGATGGCCAT 1921 GACTGTAGCATTGGACAGCAAAGGCAGATTCCAGAGCTCACTAGCCAACCAGCAGCCAAAATGGTAAGAGTATGGCTCAG 2001 TGAGATTGTATTTAAAAATGGAAAGTGGAGGAAGACAGCACTGGGTGTCTTCTGGCTTTCACATGTGCATGCATCCGTGT 2081 GCAAACCATCATACAAGTGTTATTCCCCAAATTCCTCTTCGGGCCCGGAGAAATGATTAAGATTACTTTCTCCTCTTTCA 2161 GAGGCCCCAGGTTCAATCCCTAGTATCCACATGGGTTCACACCATCTGTACCTTCAGTTCCAGAGGATCAACTGGCCTCT 2241 TCTGGCTTCGTAGTACGCAGACAAAACACCTATATGTATTAAAAACATTGCTTCAATTTTTACCTTCAAAGGGGTACCAT 2321 ATATTCATAGCCTGTGGCTAGTCTTAAAAAGCTTATAACATTCACAGTGTTAATATACTATATAAGAGCATGTACAAAAG 2401 TTTAGAACATTTTGAGGTTATGAGAAAACTACTAGTTGGAGAGAGAGATGCTCAGGCTTAAGAGCACTGGCTGCTCGTCC 2481 AGATGGGCCCAGGTTCAGTTCCCAGCACCCACACGGCAGCTCACAACTCTCTAGAACTCTAGTTCCACGTGATCTGACAC 2561 CCTCACACAGACATGCACGCACGCAAAACATCAATGCACACAAAGTAAATGTATATAAATTCGTTAAAAAGAAAACATCT 2641 AATTTGGGTTGGTGAAATGGCTGAGCTGTTAAGAACTCTGGGAGCTTTTTCAGAGTTCCTGAGTTCAATTCCCAGCCACT 2721 ATATGGTGGCTCAGGACCATCTATAGAGGGATCTGATGCCATCTTCTGGTAAGTAGGTATACATGCAGACAGCACTCCTA 2801 CACTAAATAAATAAATTAATTAAATACTAAAAGCCTGGTAATTTATAAAATATAAGGCAAAATTAAGTGAGGGTGATTCG 2881 GGGGAAAAGATTAGTCTAGGACAGGAGTTCTCAGGTTGTGGGTTGCTATCCCTTTGGGTGGGGGTTAAAGGACCTTTTCG 2961 CAGGAGATCACATATGATAGGCAGTATGTTGAGAGCAAGCAAAAGAAACTTACTTTAAATACTTCCACTTCATTTTCAGA 3041 CTCCATTGAATCATAGGGAGAAACTAAGTTCAAGCTCCCAGGCCGTAGGGAAGCTGGGGACTTCCCAAGAGCTGAGCAGC 3121 TTCTATTATGGGGAAACAGTTGTCTGAGTTCAAACAGCTCAAGAACAACTCCATCTTGCTGGCAGAGTCATACATACTAA 3201 GTTCATGTTCCCAGGTCCAGGAACCTACTCCTAACCTGTTTGGTGAAAACTCCCTTGCTCAGCCCCTTGTGTCAAAATAT 3281 GGTAGAGTAATGCTACAGCCTACCCCGTCCCCCTCGAGTTGTGGTCTTGTCCTTTAAATAAATATGTTGTACAATTTCTC 3361 TTCTGGTCGCAGTTCAGCTTCTGAGTCTGTTCTTTGGCTATGATTGATCAGTAGTGGCTTAATTACAATAAATGTTTTTC 3441 ATCTGCATTG Target sites
Provided by authors
Predicted by miRanda
DRVs
SNPs
DRVs & SNPs
|
Experimental Support 1 for Functional miRNA-Target Interaction | |||||||
---|---|---|---|---|---|---|---|
miRNA:Target | ---- | ||||||
Validation Method |
|
||||||
Conditions | C2C12 | ||||||
Location of target site | 3'UTR | ||||||
Tools used in this research | TargetScan , miRTarCLIP , Piranha | ||||||
Original Description (Extracted from the article) |
...
HITS-CLIP data was present in GSM1385343. RNA binding protein: 聽AGO2. Condition:C2C12_DM_Ago2_CLIP-Seq_myotubes
... - Zhang X; Zuo X; Yang B; Li Z; Xue Y; Zhou et al., 2014, Cell. |
||||||
miRNA-target interactions (Provided by authors) |
|
||||||
Article |
- Zhang X; Zuo X; Yang B; Li Z; Xue Y; Zhou et al. - Cell, 2014
MicroRNAs are well known to mediate translational repression and mRNA degradation in the cytoplasm. Various microRNAs have also been detected in membrane-compartmentalized organelles, but the functional significance has remained elusive. Here, we report that miR-1, a microRNA specifically induced during myogenesis, efficiently enters the mitochondria where it unexpectedly stimulates, rather than represses, the translation of specific mitochondrial genome-encoded transcripts. We show that this positive effect requires specific miR:mRNA base-pairing and Ago2, but not its functional partner GW182, which is excluded from the mitochondria. We provide evidence for the direct action of Ago2 in mitochondrial translation by crosslinking immunoprecipitation coupled with deep sequencing (CLIP-seq), functional rescue with mitochondria-targeted Ago2, and selective inhibition of the microRNA machinery in the cytoplasm. These findings unveil a positive function of microRNA in mitochondrial translation and suggest a highly coordinated myogenic program via miR-1-mediated translational stimulation in the mitochondria and repression in the cytoplasm.
LinkOut: [PMID: 25083871]
|
CLIP-seq Support 1 for dataset GSM1385343 | |
---|---|
Method / RBP | HITS-CLIP / AGO2 |
Cell line / Condition | C2C12 / C2C12_DM_Ago2_CLIP-Seq_myotubes |
Location of target site | NM_021323 | 3UTR | GGUUUACUCAUUUACUGUGUGUGUGUAUAUA |
Tools used in this analysis | TargetScan, miRTarCLIP, and Piranha |
Article / Accession Series | PMID: 25083871 / GSE57596 |
CLIP-seq Viewer | Link |
39 mmu-miR-1194 Target Genes:
Functional analysis:
ID | Target | Description | Validation methods | |||||||||
Strong evidence | Less strong evidence | |||||||||||
MIRT577399 | Usp29 | ubiquitin specific peptidase 29 | 2 | 2 | ||||||||
MIRT578645 | Gtf2h2 | general transcription factor II H, polypeptide 2 | 2 | 4 | ||||||||
MIRT583791 | Elf1 | E74-like factor 1 | 2 | 2 | ||||||||
MIRT585587 | Tox4 | TOX high mobility group box family member 4 | 2 | 4 | ||||||||
MIRT585769 | Spg21 | SPG21, maspardin | 2 | 2 | ||||||||
MIRT586369 | Pctp | phosphatidylcholine transfer protein | 2 | 6 | ||||||||
MIRT586934 | H2-T24 | histocompatibility 2, T region locus 24 | 2 | 4 | ||||||||
MIRT587278 | Fam154b | stabilizer of axonemal microtubules 2 | 2 | 2 | ||||||||
MIRT589358 | Osbpl8 | oxysterol binding protein-like 8 | 2 | 4 | ||||||||
MIRT591418 | Cd300a | CD300A molecule | 2 | 4 | ||||||||
MIRT594881 | Lpar6 | lysophosphatidic acid receptor 6 | 2 | 2 | ||||||||
MIRT594899 | Hs6st2 | heparan sulfate 6-O-sulfotransferase 2 | 2 | 2 | ||||||||
MIRT595087 | Unc5d | unc-5 netrin receptor D | 2 | 2 | ||||||||
MIRT595608 | Jazf1 | JAZF zinc finger 1 | 2 | 2 | ||||||||
MIRT595914 | Syne2 | spectrin repeat containing, nuclear envelope 2 | 2 | 2 | ||||||||
MIRT596713 | Ybey | ybeY metallopeptidase | 2 | 2 | ||||||||
MIRT597013 | Thoc6 | THO complex 6 | 2 | 2 | ||||||||
MIRT597522 | Rbak | RB-associated KRAB zinc finger | 2 | 2 | ||||||||
MIRT598050 | Nip7 | NIP7, nucleolar pre-rRNA processing protein | 2 | 2 | ||||||||
MIRT598082 | Neu3 | neuraminidase 3 | 2 | 2 | ||||||||
MIRT598528 | Itsn1 | intersectin 1 (SH3 domain protein 1A) | 2 | 2 | ||||||||
MIRT598953 | Ggps1 | geranylgeranyl diphosphate synthase 1 | 2 | 2 | ||||||||
MIRT598967 | Gata5 | GATA binding protein 5 | 2 | 2 | ||||||||
MIRT599086 | Efcab4a | calcium release activated channel regulator 2B | 2 | 2 | ||||||||
MIRT599348 | Commd7 | COMM domain containing 7 | 2 | 2 | ||||||||
MIRT599554 | C3ar1 | complement component 3a receptor 1 | 2 | 2 | ||||||||
MIRT600166 | Xpo7 | exportin 7 | 2 | 2 | ||||||||
MIRT600668 | March5 | membrane-associated ring finger (C3HC4) 5 | 2 | 2 | ||||||||
MIRT600971 | Dlc1 | deleted in liver cancer 1 | 2 | 2 | ||||||||
MIRT601455 | Tnfsf10 | tumor necrosis factor (ligand) superfamily, member 10 | 2 | 2 | ||||||||
MIRT601502 | Tmem88b | transmembrane protein 88B | 2 | 2 | ||||||||
MIRT601514 | Tmem151a | transmembrane protein 151A | 2 | 2 | ||||||||
MIRT601558 | T2 | brachyury 2 | 2 | 2 | ||||||||
MIRT601925 | Onecut3 | one cut domain, family member 3 | 2 | 2 | ||||||||
MIRT601984 | Mzt1 | mitotic spindle organizing protein 1 | 2 | 2 | ||||||||
MIRT602669 | Car5b | carbonic anhydrase 5b, mitochondrial | 2 | 2 | ||||||||
MIRT603331 | Slc35d2 | solute carrier family 35, member D2 | 2 | 2 | ||||||||
MIRT605546 | Ppp1r16b | protein phosphatase 1, regulatory (inhibitor) subunit 16B | 2 | 2 | ||||||||
MIRT606291 | Nrcam | neuronal cell adhesion molecule | 2 | 2 |
miRNA-Drug Associations | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|